Co-Authors
This is a "connection" page, showing publications co-authored by Paul SHAFER and ANN LEEN.
Connection Strength
0.544
-
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 Jan 19.
Score: 0.246
-
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing. Cytotherapy. 2024 Mar; 26(3):266-275.
Score: 0.246
-
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11).
Score: 0.053